China National Medicines Corporation Ltd. (SHA:600511)
China
· Delayed Price · Currency is CNY 28.76
+0.20 (0.70%)
Apr 28, 2026, 3:00 PM CST
SHA:600511 Revenue
China National Medicines Corporation had revenue of 13.56B CNY in the quarter ending March 31, 2026, with 6.63% growth. This brings the company's revenue in the last twelve months to 53.31B, up 4.15% year-over-year. In the year 2025, China National Medicines Corporation had annual revenue of 52.47B with 3.70% growth.
Revenue (ttm)
53.31B
Revenue Growth
+4.15%
P/S Ratio
0.41
Revenue / Employee
17.63M
Employees
3,024
Market Cap
21.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 52.47B | 1.87B | 3.70% |
| Dec 31, 2024 | 50.60B | 901.40M | 1.81% |
| Dec 31, 2023 | 49.70B | 4.20B | 9.23% |
| Dec 31, 2022 | 45.50B | -970.02M | -2.09% |
| Dec 31, 2021 | 46.47B | 6.09B | 15.08% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jointown Pharmaceutical Group | 157.71B |
| Liaoning Cheng Da | 9.90B |
| China Meheco Group | 35.36B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 78.46B |
| Qingdao Baheal Medical INC. | 7.58B |
| China National Accord Medicines Corporation | 72.95B |
| C.Q. Pharmaceutical Holding | 82.27B |
| Shanghai Pharmaceuticals Holding | 283.58B |